1.06
price down icon0.93%   -0.01
after-market After Hours: 1.04 -0.02 -1.89%
loading
Pmv Pharmaceuticals Inc stock is traded at $1.06, with a volume of 66,482. It is down -0.93% in the last 24 hours and up +20.70% over the past month. PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
See More
Previous Close:
$1.07
Open:
$1.07
24h Volume:
66,482
Relative Volume:
0.30
Market Cap:
$61.82M
Revenue:
-
Net Income/Loss:
$-51.47M
P/E Ratio:
-1.06
EPS:
-1
Net Cash Flow:
$-47.50M
1W Performance:
-0.93%
1M Performance:
+20.70%
6M Performance:
-29.80%
1Y Performance:
-34.57%
1-Day Range:
Value
$1.03
$1.0901
1-Week Range:
Value
$1.03
$1.18
52-Week Range:
Value
$0.81
$1.82

Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile

Name
Name
Pmv Pharmaceuticals Inc
Name
Phone
(609) 642-6670
Name
Address
400 ALEXANDER PARK DRIVE, PRINCETON
Name
Employee
47
Name
Twitter
Name
Next Earnings Date
2025-03-04
Name
Latest SEC Filings
Name
PMVP's Discussions on Twitter

Compare PMVP with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
PMVP
Pmv Pharmaceuticals Inc
1.06 61.82M 0 -51.47M -47.50M -1.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.20 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
525.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
326.09 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
551.22 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
242.07 28.51B 3.81B -644.79M -669.77M -6.24

Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-08-24 Upgrade Oppenheimer Perform → Outperform
May-13-24 Initiated Craig Hallum Buy
Apr-12-24 Initiated Jefferies Buy
Dec-27-23 Initiated Ladenburg Thalmann Buy
Mar-02-22 Upgrade Oppenheimer Perform → Outperform
Sep-22-21 Upgrade Goldman Neutral → Buy
Aug-19-21 Initiated Oppenheimer Perform
Aug-02-21 Initiated Guggenheim Buy
Jul-29-21 Initiated H.C. Wainwright Buy
Oct-20-20 Initiated BofA Securities Buy
Oct-20-20 Initiated Cowen Outperform
Oct-20-20 Initiated Evercore ISI Outperform
Oct-20-20 Initiated Goldman Neutral
View All

Pmv Pharmaceuticals Inc Stock (PMVP) Latest News

pulisher
Jun 10, 2025

Millennium Management LLC Has $480,000 Position in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stake in indie Semiconductor, Inc. (NASDAQ:INDI) - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 12,462 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

Squarepoint Ops LLC Increases Stake in Westwater Resources, Inc. (NASDAQ:WWR) - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

Squarepoint Ops LLC Acquires 29,722 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

G-III Apparel Group (NASDAQ:GIII) Price Target Lowered to $18.00 at Barclays - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

Blue Bird Co. (NASDAQ:BLBD) Shares Sold by California State Teachers Retirement System - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

pmv pharmaceuticals holds virtual annual meeting, elects directors By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

pmv pharmaceuticals holds virtual annual meeting, elects directors - Investing.com

Jun 09, 2025
pulisher
Jun 09, 2025

PMV Pharmaceuticals Holds 2025 Annual Stockholder Meeting - TipRanks

Jun 09, 2025
pulisher
Jun 09, 2025

Jane Street Group LLC Has $75,000 Holdings in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

Two Sigma Investments LP Buys 23,931 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

GAMMA Investing LLC Has $11.48 Million Stake in News Co. (NASDAQ:NWS) - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

Ameriprise Financial Inc. Sells 16,715 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

Bank of America Corp DE Has $932,000 Stake in KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

Citadel Advisors LLC Purchases New Position in Invesco S&P SmallCap Consumer Staples ETF (NASDAQ:PSCC) - Defense World

Jun 08, 2025
pulisher
Jun 05, 2025

Water Technologies International (OTCMKTS:WTII) Shares Pass Above 200-Day Moving Average – Here’s What Happened - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

First Trust North American Energy Infrastructure Fund (NYSEARCA:EMLP) Stock Price Passes Above 200-Day Moving Average – Should You Sell? - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Halma (LON:HLMA) Share Price Crosses Above 200 Day Moving Average – What’s Next? - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Saputo (TSE:SAP) Stock Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Persimmon (LON:PSN) Stock Passes Above Two Hundred Day Moving Average – Time to Sell? - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Solstice Gold (CVE:SGC) Shares Pass Above Two Hundred Day Moving Average – Here’s What Happened - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Bowl America (NYSEAMERICAN:BWL.A) Shares Pass Above Two Hundred Day Moving Average – Time to Sell? - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Northern Trust Corp Has $162,000 Position in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

Pre-market Movers: LYRA, INM, OGEN, VERA... - RTTNews

Jun 02, 2025
pulisher
May 28, 2025

Pre-market Movers: SPRO, ASBP, IFRX, IMNN... - RTTNews

May 28, 2025
pulisher
May 24, 2025

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - The Manila Times

May 24, 2025
pulisher
May 23, 2025

PMV Pharmaceuticals to Participate at Upcoming Investor Conferen - GuruFocus

May 23, 2025
pulisher
May 23, 2025

PMV Pharmaceuticals to Participate at Upcoming Investor Conferences | PMVP Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

PMV Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences on Oncology Innovation and Healthcare Advances - Nasdaq

May 23, 2025
pulisher
May 23, 2025

PMV Pharmaceuticals to Participate at Upcoming Investor Conferences - GlobeNewswire

May 23, 2025
pulisher
May 23, 2025

PMV Pharma CEO Reveals Latest Oncology Innovation Strategy at Two Major Healthcare Conferences - Stock Titan

May 23, 2025
pulisher
May 22, 2025

D. E. Shaw & Co. Inc. Sells 16,189 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World

May 22, 2025
pulisher
May 21, 2025

Gotham Asset Management LLC Sells 176,437 Shares of Gain Therapeutics, Inc. (NASDAQ:GANX) - Defense World

May 21, 2025
pulisher
May 20, 2025

These 3 Dividend Stocks Yield More Than 6% and Their Payouts Look Safe - The Globe and Mail

May 20, 2025
pulisher
May 18, 2025

We're Keeping An Eye On PMV Pharmaceuticals' (NASDAQ:PMVP) Cash Burn Rate - Yahoo Finance

May 18, 2025
pulisher
May 16, 2025

Crude Prices Rise on Doubts About a US-Iran Nuclear Deal - The Globe and Mail

May 16, 2025
pulisher
May 14, 2025

Is Enbridge Stock Still Worth Owning After Strong Q1 Earnings? - The Globe and Mail

May 14, 2025
pulisher
May 10, 2025

PMVP Advances PYNNACLE Trial with Steady Enrollment | PMVP Stock News - GuruFocus

May 10, 2025
pulisher
May 10, 2025

PMV Pharmaceuticals Reports Q1 2025 Financial Results - TipRanks

May 10, 2025
pulisher
May 09, 2025

PMV Pharmaceuticals Reports First Quarter 2025 Financial Results and Corporate Highlights | PMVP Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

PMV Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

PMV Pharmaceuticals Reports First Quarter 2025 Financial Results and Corporate Highlights - GlobeNewswire

May 09, 2025
pulisher
May 09, 2025

PMVP Reports First Quarter Cash Position and Operational Spendin - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Randy A. Bowman Appointed Chairman of the Board at Westwood Holdings Group - The Manila Times

May 09, 2025
pulisher
May 09, 2025

PMV Pharmaceuticals Reports Progress in Phase 2 PYNNACLE Trial and First Quarter 2025 Financial Results - Nasdaq

May 09, 2025
pulisher
May 08, 2025

JPMorgan Chase & Co. Buys 23,559 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World

May 08, 2025
pulisher
May 07, 2025

In the Green: PMV Pharmaceuticals Inc (PMVP) Closes at 0.87, Up/Down -7.34 from Previous Day - DWinneX

May 07, 2025
pulisher
May 06, 2025

I Update My Buy Recommendation for Reddit Stock - The Globe and Mail

May 06, 2025
pulisher
May 05, 2025

PMV Pharmaceuticals Inc expected to post a loss of 37 cents a shareEarnings Preview - TradingView

May 05, 2025
pulisher
May 05, 2025

Nutshell gains IND clearance for p53 Y220C reactivator NTS-071 - BioWorld MedTech

May 05, 2025

Pmv Pharmaceuticals Inc Stock (PMVP) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Pmv Pharmaceuticals Inc Stock (PMVP) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Mack David Henry
President and CEO
Jan 03 '25
Option Exercise
0.53
17,709
9,386
551,919
Jalota Deepika
Chief Development Officer
Sep 11 '24
Sale
1.50
7,218
10,853
118,283
Carulli Michael
Chief Financial Officer
Sep 11 '24
Sale
1.50
2,891
4,347
88,395
$20.66
price up icon 0.78%
$36.03
price up icon 0.45%
$21.28
price up icon 3.30%
$100.64
price up icon 1.16%
$106.47
price down icon 0.23%
biotechnology ONC
$242.07
price up icon 0.36%
Cap:     |  Volume (24h):